Eileen Rakovitch

Senior Adjunct Scientist (Full Status) ICES Central Cancer Research Program

Biography

Eileen Rakovitch is a radiation oncologist and director of the Louise Temerty Breast Cancer Centre at Sunnybrook Health Sciences Centre in Toronto. She is an associate professor and clinician scientist at the University of Toronto, a scientist at the Sunnybrook Research Institute, and an adjunct scientist at ICES. She also leads a health services research program devoted to improving the treatment and outcomes of women with ductal carcinoma in situ.

MSc, Clinical Epidemiology
FRCPC, Radiation Oncology
MD, University of Toronto

Cancer
Health services research

Radiation Oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre
Scientist, Odette Cancer Research Program, Sunnybrook Research Institute
Professor, Department of Radiation Oncology, University of Toronto

ICES Grants

Grant

2014 - 2019

The prostate cancer program project in rapid development of novel diagnostic markers for early prostate cancer (PRONTO)

Granting Agency: Prostate Cancer Canada
Principal Investigators: Bartlett J
Co-Investigators: Bauman G, Berman D, Boutros P, Buttyan R, Earle C, Finelli A, Lapointe J, Loblaw A, Park P, Rakovitch E, Saskin R, Thomson A, van der Kwast T, Venkateswaran V.
Grant Type: Movember Team Grant
Grant Amount: $4,995,400

See All

Journal Articles

Journal Article

28/06/2024

Molecular expression assays improve the prediction of local and invasive local recurrence after breast-conserving surgery for ductal carcinoma in situ

Hahn E, Sutradhar R, Paszat L, Nguyen L, Rodin D, Nofech-Mozes S, Trebinjac S, Jerzak KJ, Fong C, Rakovitch E. J Clin Oncol. 2024; JCO2302276. Epub 2024 Jun 28.

Journal Article

10/02/2024

Personalizing the treatment of women with ductal carcinoma in situ (DCIS) using the DCIS score: a qualitative study on score use

O’Brien MA, Paszat L, Makuwaza T, Fong C, Rakovitch E. Curr Oncol. 2024; 31(2):975-86. Epub 2024 Feb 10.

Journal Article

16/06/2023

Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery

Rodin D, Sutradhar R, Jerzak KJ, Hahn E, Nguyen L, Castelo M, Fatiregun O, Fong C, Mata DGMM, Trebinjac S, Paszat L, Rakovitch E. Breast Cancer Res Treat. 2023; 201(1):77-87. Epub 2023 Jun 16.

Journal Article

14/03/2023

The association between surgical axillary staging, adjuvant treatment use and survival in older women with early stage breast cancer: a population-based study

Castelo M, Sutradhar R, Faught N, Mata DGMM, Hahn E, Nguyen L, Paszat L, Rodin D, Trebinjac S, Fong C, Rakovitch E. Ann Surg Oncol. 2023; 30(7):3901-12. Epub 2023 Mar 14.

Journal Article

27/01/2022

Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy

Rodin D, Sutradhar R, Nofech-Mozes S, Gu S, Faught N, Hahn E, Fong C, Trebinjac S, Paszat L, Rakovitch E. Breast Cancer Res Treat. 2022; 192(1):223-33. Epub 2022 Jan 27.

Journal Article

28/12/2020

21-gene assay and breast cancer mortality in ductal carcinoma in situ

Rakovitch E, Sutradhar R, Nofech-Mozes S, Gu S, Fong C, Hanna W, Paszat L. J Natl Cancer Inst. 2021; 113(5):572-9. Epub 2020 Dec 28.

Journal Article

08/05/2020

The impact of ductal carcinoma in situ on health services utilization

Paszat L, Sutradhar R, Rakovitch E. Breast Cancer Res Treat. 2020; 182(1):159–68. Epub 2020 May 8.

Journal Article

11/11/2019

Low-value transthoracic echocardiography, healthcare utilization, and clinical outcomes in patients with coronary artery disease

Tharmaratnam T, Bouck Z, Sivaswamy A, Wijeysundera HC, Chu C, Yin CX, Nesbitt GC, Edwards J, Yared K, Wong B, Weinerman A, Thavendiranathan P, Rakowski H, Dorian P, Anderson G, Austin PC, Dudzinski DM, Ko DT, Weiner RB, Bhatia RS. Circ Cardiovasc Qual Outcomes. 2019; 12:e006123. Epub 2019 Nov 11.

Journal Article

31/07/2019

The time-varying effect of radiotherapy after breast-conserving surgery for DCIS

Rakovitch E, Sutradhar R, Hallett M, Thompson AM, Gu S, Dumeaux V, Whelan TJ, Paszat L. Breast Cancer Res Treat. 2019; 178(1):221-30. Epub 2019 Jul 31.

Journal Article

19/07/2019

Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery

Rakovitch E, Sutradhar R, Lalani N, Nofech-Mozes S, Gu S, Goldberg M, Hanna W, Fong C, Paszat L. Breast Cancer Res Treat. 2019; 178(1):169-76. Epub 2019 Jul 19.

See All

News Coverage

News Release

12/12/2014

Researchers validate recurrence risk test for DCIS

See All

Contact Details

Get in touch with
Eileen Rakovitch

"*" indicates required fields

Eileen Rakovitch

Biography

Education

Research Focus

Other Affiliations

ICES Grants

The prostate cancer program project in rapid development of novel diagnostic markers for early prostate cancer (PRONTO)

Journal Articles

Molecular expression assays improve the prediction of local and invasive local recurrence after breast-conserving surgery for ductal carcinoma in situ

Personalizing the treatment of women with ductal carcinoma in situ (DCIS) using the DCIS score: a qualitative study on score use

Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery

The association between surgical axillary staging, adjuvant treatment use and survival in older women with early stage breast cancer: a population-based study

Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy

21-gene assay and breast cancer mortality in ductal carcinoma in situ

The impact of ductal carcinoma in situ on health services utilization

Low-value transthoracic echocardiography, healthcare utilization, and clinical outcomes in patients with coronary artery disease

The time-varying effect of radiotherapy after breast-conserving surgery for DCIS

Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery

News Coverage

Researchers validate recurrence risk test for DCIS

Get in touch with
Eileen Rakovitch

Eileen Rakovitch

Biography

Education

Research Focus

Other Affiliations

ICES Grants

The prostate cancer program project in rapid development of novel diagnostic markers for early prostate cancer (PRONTO)

Journal Articles

Molecular expression assays improve the prediction of local and invasive local recurrence after breast-conserving surgery for ductal carcinoma in situ

Personalizing the treatment of women with ductal carcinoma in situ (DCIS) using the DCIS score: a qualitative study on score use

Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery

The association between surgical axillary staging, adjuvant treatment use and survival in older women with early stage breast cancer: a population-based study

Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy

21-gene assay and breast cancer mortality in ductal carcinoma in situ

The impact of ductal carcinoma in situ on health services utilization

Low-value transthoracic echocardiography, healthcare utilization, and clinical outcomes in patients with coronary artery disease

The time-varying effect of radiotherapy after breast-conserving surgery for DCIS

Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery

News Coverage

Researchers validate recurrence risk test for DCIS

Get in touch with Eileen Rakovitch

Get in touch with
Eileen Rakovitch